Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock $0.001 par value per share
-
Shares outstanding
-
77.8M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
+421K
-
Total reported value, excl. options
-
$145M
-
Value change
-
-$2.64M
-
Put/Call ratio
-
0.05
-
Number of buys
-
46
-
Number of sells
-
-39
-
Price
-
$4.00
Significant Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) as of Q4 2024
115 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share as of Q4 2024.
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 77.8M outstanding shares and own 46.69% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.91M shares), RA CAPITAL MANAGEMENT, L.P. (4.33M shares), Bain Capital Life Sciences Investors, LLC (4.03M shares), Siren, L.L.C. (3.75M shares), Vestal Point Capital, LP (2.85M shares), BlackRock, Inc. (1.86M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.75M shares), VANGUARD GROUP INC (1.4M shares), Finepoint Capital LP (961K shares), and JPMORGAN CHASE & CO (956K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.